论文部分内容阅读
目的:观察喜炎平超声雾化吸入治疗成人急性上呼吸道感染的疗效。方法:将成人急性上呼吸道感染患者325例随机分为3组:利巴韦林雾化组92例,喜炎平静脉滴注组103例,喜炎平雾化组130例。3组患者均在给予常规退热及对症处理的基础上进行对应治疗。观察3组治疗后临床疗效及不良反应。结果:利巴韦林雾化组总有效率为64.1%,喜炎平静脉滴注组为80.6%,喜炎平雾化组为92.3%,3组比较,差异均有显著性意义(P<0.05),喜炎平雾化组总有效率优于利巴韦林雾化组和喜炎平静脉滴注组,喜炎平静脉滴注组优于利巴韦林雾化组。利巴韦林雾化组不良反应率为7.6%,喜炎平静脉滴注组为14.6%,喜炎平雾化组为6.2%,喜炎平静脉滴注组不良反应发生率最高,高于利巴韦林雾化组和喜炎平雾化组(P<0.05)。结论:喜炎平超声雾化吸入治疗成人急性上呼吸道感染的疗效显著。
Objective: To observe the therapeutic effect of Xiyanping ultrasonic inhalation on acute upper respiratory tract infection in adults. Methods: Thirty-two adult patients with acute upper respiratory tract infection were randomly divided into three groups: 92 in ribavirin nebulization group, 103 in Xiyanping intravenous infusion group and 130 in Xiyanping nebulization group. Three groups of patients were given conventional antipyretic and symptomatic treatment based on the corresponding treatment. The clinical effects and adverse reactions of the three groups were observed. Results: The total effective rate of ribavirin atomization group was 64.1%, hippocampal CAI group was 80.6%, xiyanping atomization group was 92.3%, the difference between the three groups was significant (P < 0.05). The total effective rate of Xiyanping nebulization group was superior to that of ribavirin nebulization group and Xiyanping vein infusion group. Xiyanping intravenous infusion group was superior to ribavirin nebulization group. Adverse reactions of ribavirin atomization group were 7.6%, Xiyan Ping infusion group was 14.6%, Xiyanping atomization group was 6.2%, Xiyan Ping intravenous infusion group had the highest incidence of adverse reactions, higher than Ribavirin nebulization group and Xiyanping nebulization group (P <0.05). Conclusion: Xiyanping inhalation of ultrasound treatment of acute upper respiratory tract infection in adults a significant effect.